medioresinol has been researched along with Ischemic Stroke in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, CL; Guan, X; Kai, G; Li, F; Pang, T; Ruan, W; Wang, Y; Zhao, S | 1 |
1 other study(ies) available for medioresinol and Ischemic Stroke
Article | Year |
---|---|
Medioresinol as a novel PGC-1α activator prevents pyroptosis of endothelial cells in ischemic stroke through PPARα-GOT1 axis.
Topics: Animals; Aspartate Aminotransferase, Cytoplasmic; Chromatin Immunoprecipitation; Disease Models, Animal; Endothelium, Vascular; Fluorescent Antibody Technique; Gas Chromatography-Mass Spectrometry; HEK293 Cells; Humans; Ischemic Stroke; Lignans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred ICR; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR alpha; Pyroptosis; Rats, Sprague-Dawley | 2021 |